Cap analog and Potato virus A HC-Professional silencing suppressor enhance GFP transient expression utilizing an infectious virus vector in Nicotiana benthamiana.
Transient expression of proteins in crops has grow to be a option to facilitate recombinant protein manufacturing with its quick and simple utility. However, host defensive mechanisms have been reported to cut back the effectivity of transient expression in crops. Therefore, this examine was designed to guage the impact of cap analog and Potato virus A helper element proteinase (PVA HC-Professional) on inexperienced fluorescent protein (GFP) expression effectivity. N. benthamiana leaves have been inoculated with capped or un-capped RNA transcripts of a Turnip crinkle virus (TCV) assemble containing a inexperienced fluorescent protein reporter gene (TCV-sGFP) instead of its coat protein (CP) ORF. PVA HC-Professional as a viral suppressor of RNA silencing was infiltrated in trans by Agrobacterium tumefaciens, elevated the GFP foci diameter to 6 and much more cells in each capped and un capped therapies.
The expression degree of GFP in inoculated crops with TCV-sGFP transcript pre-infiltrated with PVA HC-Professional was 12.97-fold increased than the GFP accumulation degree in pre-infiltrated leaves with empty plasmid (EP) management.
Additionally, the yield of GFP in inoculated N. benthamiana crops with capped TCV-sGFP transcript pre-infiltrated with EP and PVA HC-Professional was 1.54 and 1.2-fold respectively, larger than the extent of GFP expressed with out cap analog utility at 5 days publish inoculation (dpi). As well as, the motion of TCV-sGFP was elevated in some cells of inoculated leaves with capped transcripts. Outcomes of this examine indicated that PVA HC-Professional and mRNA capping can enhance GFP expression and its cell to cell motion in N. benthamiana.
gfpvector
ADIPOQ-AS1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
|||
| LV718304 | ABM | 1.0 ug DNA | Ask for price |
ADIPOQ - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector |
|||
| TL314924 | Origene Technologies GmbH | 5 µg/vial | Ask for price |
ADIPOQ Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA) |
|||
| LV700826 | ABM | 1.0 ug DNA | EUR 616.8 |
ADIPOQ Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
|||
| LV700827 | ABM | 1.0 ug DNA | EUR 686.4 |
ADIPOQ Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
|||
| LV700828 | ABM | 1.0 ug DNA | EUR 686.4 |
Adipoq - Rat, 4 unique 29mer shRNA constructs in lentiviral GFP vector |
|||
| TL713071 | Origene Technologies GmbH | 5 µg/vial | Ask for price |
Adipoq - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector |
|||
| TL511679 | Origene Technologies GmbH | 5 µg/vial | Ask for price |
ADIPOQ ORF Vector (Human) (pORF) |
|||
| ORF012163 | ABM | 1.0 ug DNA | EUR 424.8 |
ADIPOQ-AS1 ORF Vector (Human) (pORF) |
|||
| ORF015332 | ABM | 1.0 ug DNA | Ask for price |
ADIPOR2 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector |
|||
| TL306814 | Origene Technologies GmbH | 5 µg/vial | Ask for price |
ADIPOR1 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector |
|||
| TL306815 | Origene Technologies GmbH | 5 µg/vial | Ask for price |
ADIPOQ Protein Vector (Human) (pPM-C-HA) |
|||
| PV048651 | ABM | 500 ng | EUR 577.2 |
ADIPOQ Protein Vector (Human) (pPB-C-His) |
|||
| PV048649 | ABM | 500 ng | EUR 577.2 |
ADIPOQ Protein Vector (Human) (pPB-N-His) |
|||
| PV048650 | ABM | 500 ng | EUR 577.2 |
ADIPOQ Protein Vector (Human) (pPM-C-His) |
|||
| PV048652 | ABM | 500 ng | EUR 577.2 |
ADIPOQ Protein Vector (Human) (pPB-His-MBP) |
|||
| PV320122 | ABM | 500 ng | EUR 577.2 |
ADIPOQ Protein Vector (Human) (pPB-His-GST) |
|||
| PV320123 | ABM | 500 ng | EUR 577.2 |
Adipor1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV) |
|||
| LV638893 | ABM | 1.0 ug DNA | EUR 818.4 |
Adipor1 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV638897 | ABM | 1.0 ug DNA | EUR 818.4 |
Adipor2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV) |
|||
| LV624697 | ABM | 1.0 ug DNA | EUR 818.4 |
Adipor2 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV624701 | ABM | 1.0 ug DNA | EUR 818.4 |
Adipor1 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV638898 | ABM | 1.0 ug DNA | EUR 818.4 |
Adipor2 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV624702 | ABM | 1.0 ug DNA | EUR 818.4 |
ADIPOQ Protein Vector (Human) (pPM-N-D-C-HA) |
|||
| PV320124 | ABM | 500 ng | EUR 662.4 |
ADIPOQ Protein Vector (Human) (pPM-N-D-C-His) |
|||
| PV320125 | ABM | 500 ng | EUR 662.4 |
ADIPOQ - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml. |
|||
| TL314924V | Origene Technologies GmbH | 500 ul each | Ask for price |
Adipor1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA) |
|||
| LV638894 | ABM | 1.0 ug DNA | EUR 818.4 |
Adipor2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA) |
|||
| LV624698 | ABM | 1.0 ug DNA | EUR 818.4 |
Adipor1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
|||
| LV638895 | ABM | 1.0 ug DNA | EUR 888 |
Adipor1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
|||
| LV638896 | ABM | 1.0 ug DNA | EUR 888 |
Adipor2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
|||
| LV624699 | ABM | 1.0 ug DNA | EUR 888 |
Adipor2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
|||
| LV624700 | ABM | 1.0 ug DNA | EUR 888 |
Adipoq ORF Vector (Rat) (pORF) |
|||
| ORF063117 | ABM | 1.0 ug DNA | EUR 607.2 |
Adipoq ORF Vector (Mouse) (pORF) |
|||
| ORF038176 | ABM | 1.0 ug DNA | EUR 114 |
ADIG Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
|||
| LV703011 | ABM | 1.0 ug DNA | EUR 540 |
ADIG Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV703015 | ABM | 1.0 ug DNA | EUR 540 |
Adipor2 - Rat, 4 unique 29mer shRNA constructs in lentiviral GFP vector |
|||
| TL703577 | Origene Technologies GmbH | 5 µg/vial | Ask for price |
Adipor1 - Rat, 4 unique 29mer shRNA constructs in lentiviral GFP vector |
|||
| TL713861 | Origene Technologies GmbH | 5 µg/vial | Ask for price |
ADIG Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV703016 | ABM | 1.0 ug DNA | EUR 540 |
Adipor2 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector |
|||
| TL504153 | Origene Technologies GmbH | 5 µg/vial | Ask for price |
Adipor1 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector |
|||
| TL517189 | Origene Technologies GmbH | 5 µg/vial | Ask for price |
ADIPOQ sgRNA CRISPR Lentivector set (Human) |
|||
| K0050401 | ABM | 3 x 1.0 ug | EUR 406.8 |
ESR1 Lentiviral Vector (Human) (pLenti-II) |
|||
| LV010008 | ABM | 1.0 ug DNA | EUR 379.2 |
ADIPOQ - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector |
|||
| TG314924 | Origene Technologies GmbH | 5 µg/vial | Ask for price |
ADIPOQ Protein Vector (Rat) (pPM-C-HA) |
|||
| PV252468 | ABM | 500 ng | EUR 723.6 |
ADIG Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA) |
|||
| LV703012 | ABM | 1.0 ug DNA | EUR 540 |
ADIPOQ Protein Vector (Rat) (pPB-C-His) |
|||
| PV252466 | ABM | 500 ng | EUR 723.6 |
ADIPOQ Protein Vector (Rat) (pPB-N-His) |
|||
| PV252467 | ABM | 500 ng | EUR 723.6 |
ADIPOQ Protein Vector (Rat) (pPM-C-His) |
|||
| PV252469 | ABM | 500 ng | EUR 723.6 |
ADIPOQ - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector |
|||
| TR314924 | Origene Technologies GmbH | 5 µg/vial | Ask for price |
ADIPOQ Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV152704 | ABM | 500 ng | EUR 723.6 |
ADIG Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
|||
| LV703013 | ABM | 1.0 ug DNA | EUR 609.6 |
ADIG Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
|||
| LV703014 | ABM | 1.0 ug DNA | EUR 609.6 |
ADIPOQ sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
| K0050402 | ABM | 1.0 ug DNA | EUR 184.8 |
ADIPOQ sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
| K0050403 | ABM | 1.0 ug DNA | EUR 184.8 |
ADIPOQ sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
| K0050404 | ABM | 1.0 ug DNA | EUR 184.8 |
ADIPOQ Protein Vector (Mouse) (pPB-C-His) |
|||
| PV152702 | ABM | 500 ng | EUR 723.6 |
ADIPOQ Protein Vector (Mouse) (pPB-N-His) |
|||
| PV152703 | ABM | 500 ng | EUR 723.6 |
ADIPOQ Protein Vector (Mouse) (pPM-C-His) |
|||
| PV152705 | ABM | 500 ng | EUR 723.6 |
Adipoq - Rat shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml. |
|||
| TL713071V | Origene Technologies GmbH | 500 ul each | Ask for price |
ADI1 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector |
|||
| TL306816 | Origene Technologies GmbH | 5 µg/vial | Ask for price |
Adipoq - Mouse shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml. |
|||
| TL511679V | Origene Technologies GmbH | 500 ul each | Ask for price |
IV Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
|||
| LV730175 | ABM | 1.0 ug DNA | Ask for price |
IV Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV730179 | ABM | 1.0 ug DNA | Ask for price |
HP Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
|||
| LV703719 | ABM | 1.0 ug DNA | EUR 540 |
HP Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV703723 | ABM | 1.0 ug DNA | EUR 540 |
C5 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
|||
| LV704421 | ABM | 1.0 ug DNA | EUR 540 |
C5 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV704425 | ABM | 1.0 ug DNA | EUR 540 |
MS Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
|||
| LV734267 | ABM | 1.0 ug DNA | Ask for price |
MS Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV734271 | ABM | 1.0 ug DNA | Ask for price |
NA Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
|||
| LV735845 | ABM | 1.0 ug DNA | Ask for price |
NA Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV735849 | ABM | 1.0 ug DNA | Ask for price |
NM Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
|||
| LV736283 | ABM | 1.0 ug DNA | Ask for price |
NM Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV736287 | ABM | 1.0 ug DNA | Ask for price |
S7 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
|||
| LV747677 | ABM | 1.0 ug DNA | Ask for price |
S7 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV747681 | ABM | 1.0 ug DNA | Ask for price |
P1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
|||
| LV739457 | ABM | 1.0 ug DNA | Ask for price |
P1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739461 | ABM | 1.0 ug DNA | Ask for price |
CS Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
|||
| LV709011 | ABM | 1.0 ug DNA | EUR 379.2 |
CS Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV709015 | ABM | 1.0 ug DNA | EUR 379.2 |
Environment friendly manufacturing of recombinant adeno-associated viral vector, serotype DJ/8, carrying the GFP gene.
The aim of this examine was to determine an environment friendly technique for the preparation of an adeno-associated viral (AAV), serotype DJ/8, carrying the GFP gene (AAV-DJ/8-GFP). We in contrast the yields of AAV-DJ/Eight vector, which have been produced by three completely different mixture strategies, consisting of two plasmid DNA transfection strategies (lipofectamine and calcium phosphate co-precipitation; CaPi) and two virus DNA purification strategies (iodixanol and cesium chloride; CsCl). The outcomes confirmed that the very best yield of AAV-DJ/8-GFP vector was completed with the mixture technique of lipofectamine transfection and iodixanol purification.
The viral protein expression ranges and the transduction efficacy in HEK293 and CHO cells weren’t completely different amongst 4 completely different mixture strategies for AAV-DJ/8-GFP vectors. We confirmed that the AAV-DJ/8-GFP vector might transduce to human and murine hepatocyte-derived cell traces. These outcomes present that AAV-DJ/8-GFP, purified by the mixture of lipofectamine and iodixanol, produces an environment friendly yield with out altering the traits of protein expression and AAV gene transduction
A CGMMV genome-replicon vector with partial sequences of coat protein gene effectively expresses GFP in Nicotiana benthamiana.
A extremely infectious clone of Cucumber inexperienced mottle mosaic virus (CGMMV), a cucurbit-infecting tobamovirus was utilized for designing of gene expression vectors. Two variations of vector have been examined for his or her efficacy in expressing the inexperienced fluorescent protein (GFP) in Nicotiana benthamiana. When the GFP gene was inserted on the cease codon of coat protein (CP) gene of the CGMMV genome with none read-through codon, systemic expression of GFP, in addition to virion formation and systemic signs expression have been obtained in N. benthamiana.
The qRT-PCR evaluation confirmed 23 fold enhance of GFP over actin at 10days publish inoculation (dpi), which elevated to 45 fold at 14dpi and thereafter the GFP expression was considerably declined. Additional, we present that when the a lot of the CP sequence is deleted retaining solely the primary 105 nucleotides, the shortened vector containing GFP in body of authentic CP open studying body (ORF) resulted in 234 fold enhance of GFP expression over actin at 5dpi in N. benthamiana with out the formation of virions and illness signs. Our examine demonstrated {that a} easy manipulation of CP gene within the CGMMV genome whereas preserving the translational body of CP resulted in growing a virus-free, fast and environment friendly international protein expression system within the plant. The CGMMV primarily based vectors developed on this examine could also be probably helpful for the manufacturing of edible vaccines in cucurbits
Titanium Cup Tip, 250 ml |
|||
| 0-120-0019 | Biologics | 250 ml | EUR 1377 |
|
Description: includes Interface Washers |
|||
Microtube Tray, 8 Position (for 250 ml Cup Tip) |
|||
| 0-120-0021 | Biologics | each | EUR 113 |
|
Description: includes Interface Washers |
|||
Continuous Flow Chamber |
|||
| 0-120-0026 | Biologics | each | EUR 774 |
|
Description: includes Interface Washers |
|||
Interface Washers 1.5” Diameter, 5/Pkg |
|||
| 0-120-003 | Biologics | 1.5'' Diameter | EUR 31 |
13 mm Diameter Solid Titanium Extender Tip |
|||
| 0-120-0032 | Biologics | 13 mm | EUR 301 |
13 mm Diameter Tapped Titanium Extender Tip |
|||
| 0-120-0033 | Biologics | 13 mm | EUR 362 |
19 mm Diameter Solid Titanium Extender Tip |
|||
| 0-120-0034 | Biologics | 19 mm | EUR 315 |
19 mm Diameter Tapped Titanium Extender Tip |
|||
| 0-120-0035 | Biologics | 19 mm | EUR 375 |
25 mm Diameter Solid Titanium Extender Tip |
|||
| 0-120-0036 | Biologics | 25 mm | EUR 328 |
25 mm Diameter Tapped Titanium Extender Tip |
|||
| 0-120-0037 | Biologics | 25 mm | EUR 389 |
KoldPod, 1.5ml Micro Tube |
|||
| 0-120-0038 | Biologics | 1.5 ml | EUR 152 |
|
Description: Thermo conductive tube pods |
|||
KoldPod, 15ml Conical Tube |
|||
| 0-120-0039 | Biologics | 15 ml | EUR 275 |
|
Description: Thermo conductive tube pods |
|||
KoldPod, 50ml Conical Tube |
|||
| 0-120-0040 | Biologics | 50 ml | EUR 290 |
|
Description: Thermo conductive tube pods |
|||
Model 150 V/T Ultrasonic Homogenizer |
|||
| 0-121-0002 | Biologics | 210-240V/50-60Hz | EUR 2920 |
|
Description: Delivers up to 150 Watts of ultrasonic power to the Titanium Tip. The Timer and Duty Cycle function increase preciosion in sample processing processing. |
|||
Model 300 V/T Ultrasonic Homogenizer |
|||
| 0-122-0002 | Biologics | 210-240V/50-60Hz | EUR 3520 |
|
Description: Delivers up to 300 Watts of ultrasonic power to the Titanium Tip. The Timer and Duty Cycle function increase preciosion in sample. |
|||
SONABOZ Sound Abating Chamber |
|||
| 0-125-0001 | Biologics | each | EUR 1020 |
|
Description: Reduces cavitational sound emitted during processing. |
|||
Model 3000 Ultrasonic Homogenizer |
|||
| 0-127-0002 | Biologics | 210-240V/50-60Hz | EUR 4120 |
|
Description: Delivers up to 300 Watts of ultrasonic power to the Titanium Tip and includes an intergrated Sound Abating Chmaber to reduce cavitational sound emitted during processing. The Timer and Duty Cycle function increase preciosion in sample. |
|||
Model 3000MP Ultrasonic Homogenizer |
|||
| 0-128-0002 | Biologics | 210-240V/50-60Hz | EUR 4720 |
|
Description: Delivers up to 300 Watts of ultrasonic power to the Titanium Tip with preciosion control from a microprocessor and a graphical user interface displayed on a large (145 mm) LCD display. The integrated Sound Abating Chamber reduces cavitational sound emitted during processing. |
|||
OMNICON® Zone Reader, 210-240V/50-60Hz |
|||
| 0-131-0002 | Biologics | 210-240V/50-60Hz | EUR 35200 |
|
Description: Designed to Perform multi-plate Assays on round 90/100mm Petri Dishes. The integrated LED illumination system provides transmitted light for brightfield and darkfield illumination of transparent media. |
|||
OMNI-Noculator Peni Cylinder Filler, 210-240V/50-60Hz |
|||
| 0-134-0002 | Biologics | 210-240V/50-60Hz | EUR 32200 |
|
Description: A robotic liquid handling system designed to dispense Peni Cylinders and fill Peni Cylinders with the corresponding antibiotic liquid sample. |
|||
Peni Cylinder Dispenser with Manual Hopper |
|||
| 0-144-0002 | Biologics | each | EUR 5406 |
|
Description: Dispenser can be configured to dispense 4 or 6 Peni Cylinders onto a petri dish. |
|||
Peni Cylinder Dispenser with Motorized Hopper, 100-240V/50-60Hz |
|||
| 0-144-0003 | Biologics | 100-240V/50-60Hz | EUR 6254 |
|
Description: The motorized hopper can be configured to dispense 4 or 6 Peni Cylinders onto a petri Dispenser can be disassembled for disinfection. |
|||
Stainless Steel Peni Cylinder with Flat Face |
|||
| 0-144-0005 | Biologics | 6mm I.D. x 8mm O.D. x 10mm Long | EUR 399 |
|
Description: sold in packages of 100 pieces |
|||
Stainless Steel Peni Cylinder with Chamfered Face |
|||
| 0-144-0006 | Biologics | 6mm I.D. x 8mm O.D. x 10mm Long | EUR 412 |
|
Description: sold in packages of 100 pieces |
|||
Custom development of ELISAs for other species or antibody isotypes not listed in the catalog. Custom testing of samples for IgG/IgM/IgA or total (IgG+IgM+IgA) |
|||
| 000-CUS | Alpha Diagnostics | Custom | EUR 602 |
Alpha-Bungarotoxin, CF®405S, 500 ug |
|||
| 00002 | Biotium | 1UG | EUR 527 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-bungarotoxin, CF405s |
|||
| 00002 | Cusabio | 500uG | EUR 594 |
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Alpha-Bungarotoxin, CF®405S, 500 ug |
|||
| 00002-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®405S 100ug |
|||
| 00002-100ug | Biotium | 100uG | EUR 132 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®680R, 500 ug |
|||
| 9-00003 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®680R, 500 ug |
|||
| 00003-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®680R 100ug |
|||
| 9-00003 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®640R, 500 ug |
|||
| 9-00004 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®640R, 500 ug |
|||
| 00004-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®640R 100ug |
|||
| 9-00004 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®488A, 500 ug |
|||
| 9-00005 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®488A, 500 ug |
|||
| 00005-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin CF®488A 100ug |
|||
| 9-00005 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®568, 500 ug |
|||
| 9-00006 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®568, 500 ug |
|||
| 00006-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®568 100ug |
|||
| 9-00006 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®594, 500 ug |
|||
| 9-00007 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®594, 500 ug |
|||
| 00007-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin CF®594 100ug |
|||
| 9-00007 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®633, 500 ug |
|||
| 9-00009 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®633, 500 ug |
|||
| 00009-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®633 100ug |
|||
| 9-00009 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
SARS-CoV-2 Indicator Cell Line for RNA Replication - GFP Reporter only |
|||
| 0001-PP-001 | IBT Bioservices | 1 cell line (can order x amount) | EUR 12000 |
|
Description: SARS-CoV-2 GFP reporter cell line using HEK293T (ACE2/TMPRSS2) cells |
|||
Alpha-Bungarotoxin, 1 mg |
|||
| 00010-1 | Biotium | 1MG | EUR 193 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, 1 mg |
|||
| 00010-1-1 | Biotium | EA | EUR 193 |
Fluorescein-Alpha-Bungarotoxin, 500 ug |
|||
| 00011 | Biotium | 500uG | EUR 376 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Fluorescein-Alpha-Bungarotoxin, 500 ug |
|||
| 00011-1 | Biotium | EA | EUR 376 |
Tetramethylrhodamine-Alpha-Bungarotoxin, 500 ug |
|||
| 00012 | Biotium | 500uG | EUR 394 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Tetramethylrhodamine-Alpha-Bungarotoxin, 500 ug |
|||
| 00012-1 | Biotium | EA | EUR 394 |
Fluorescein-alpha-bungarotoxin, 10x50ug |
|||
| 00013 | Biotium | 10ST | EUR 436 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Fluorescein-alpha-bungarotoxin, 10x50ug |
|||
| 00013-1 | Biotium | EA | EUR 436 |
Tetramethylrhodamine-A-Bungarotoxin, 10x50 ug |
|||
| 00014 | Biotium | 10ST | EUR 494 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Tetramethylrhodamine-A-Bungarotoxin, 10x50 ug |
|||
| 00014-1 | Biotium | EA | EUR 494 |
Sulforhodamine 101-Alpha-Bungarotoxin, 500 ug |
|||
| 00015 | Biotium | 500uG | EUR 494 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Sulforhodamine 101-Alpha-Bungarotoxin, 500 ug |
|||
| 00015-1 | Biotium | EA | EUR 494 |
Sulforhodamine 101-Alpha-Bungarotoxin, 50 ug |
|||
| 00016 | Biotium | 10ST | EUR 560 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Sulforhodamine 101-Alpha-Bungarotoxin, 50 ug |
|||
| 00016-1 | Biotium | EA | EUR 560 |
Biotin-XX-A-Bungarotoxin, 500 ug |
|||
| 00017 | Biotium | 500uG | EUR 455 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Biotin-XX-A-Bungarotoxin, 500 ug |
|||
| 00017-1 | Biotium | EA | EUR 455 |
Alpha-Bungarotoxin, CF®555, 500 ug |
|||
| 9-00018 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®555, 500 ug |
|||
| 00018-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®555 100ug |
|||
| 9-00018 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Acrylamide, Chemzymes Ultra Pure® |
|||
| 00019-100 | Polysciences Europe GmbH | 100g | EUR 101.52 |
|
Description: 79-06-1 |
|||
Acrylamide, Chemzymes Ultra Pure® |
|||
| 00019-500 | Polysciences Europe GmbH | 500g | EUR 270 |
|
Description: 79-06-1 |
|||
Biotin-cAMP, 1 mg |
|||
| 00020 | Biotium | 1MG | EUR 298 |
|
Description: N/A |
|||
Biotin-cAMP, 1 mg |
|||
| 00020-1 | Biotium | 20ST | EUR 298 |
|
Description: N/A |
|||
Biotin-cAMP, 50 ug |
|||
| 00020-1-1 | Biotium | EA | EUR 414 |
Biotin-cGMP, 1 mg |
|||
| 00021 | Biotium | 1MG | EUR 331 |
|
Description: N/A |
|||
Biotin-cGMP, 1 mg |
|||
| 00021-1 | Biotium | 20ST | EUR 331 |
|
Description: N/A |
|||
Biotin-cGMP, 20x50 ug |
|||
| 00021-1-1 | Biotium | EA | EUR 447 |
Cyanine 644-cAMP, 1 mg |
|||
| 00022 | Biotium | 1MG | EUR 496 |
|
Description: N/A |
|||
Cyanine 644-cAMP, 1 mg |
|||
| 00022-1 | Biotium | 20ST | EUR 496 |
|
Description: N/A |
|||
Cyanine 644-cAMP, 20x50 ug |
|||
| 00022-1-1 | Biotium | EA | EUR 647 |
Fluorescein Methotrexate, Triammonium Salt, 1 mg |
|||
| 00023 | Biotium | 1MG | EUR 285 |
|
Description: N/A |
|||
Fluorescein Methotrexate, Triammonium Salt, 1 mg |
|||
| 00023-1 | Biotium | EA | EUR 285 |
Staurosporine |
|||
| 00025 | Biotium | 100uG | EUR 100 |
|
Description: N/A |
|||
Staurosporine |
|||
| 00025-1 | Biotium | EA | EUR 100 |
Alpha-Bungarotoxin, CF®543, 500 ug |
|||
| 00026 | Biotium | 500uG | EUR 527 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®543, 500 ug |
|||
| 00026-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®543, 100 ug |
|||
| 00026-100ug | Biotium | 1UG | EUR 132 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Rhodamine Phalloidin 300U |
|||
| 00027 | Biotium | 300 | EUR 364 |
|
Description: N/A |
|||